Pharmaceuticals
10 combination product development experts
These ten professionals have led device and combination product development inside pharmaceutical and biotech companies, with combination products named in their own job titles. A reader can learn how drug makers organize and run drug-device combination product programs.
Professionals to explore
01—10Chris Mitchener
LinkedInExperience: Exec. Director Device & Combination Product Development · Eli Lilly and Company
Exec. Director Device & Combination Product Development at Eli Lilly and Company since March 2023, a role the profile describes as carrying leadership and program and platform management responsibility for device and biotech product R&D. Also Sr. Director Device & Combination Product Development (2015–2023) and Assoc. Director Device & Combination Product Development (2006–2011) at Eli Lilly and Company.
Chris Smith
LinkedInExperience: Director, Combination Product Devices · Teva Pharmaceuticals
Director, Combination Product Devices at Teva Pharmaceuticals since January 2020. The profile describes heading the pen injector technology cluster, managing a multi-disciplinary team of engineers, technicians and project managers, and delivering a portfolio of pen-injector combination projects through development, verification, validation, submission and transfer to production. Also Head of Engineering, Steriles Device Team at Teva (2018–2019).
Jeffrey C. Givand
LinkedInExperience: Director Of Device and Combination Product Development · Merck
Former Director Of Device and Combination Product Development at Merck (2013–2021), and Executive Director at Merck from 2021 to 2026. The profile summary describes leadership experience in both pharmaceutical drug product and process development and drug-device combination product development. Other listed Merck roles include Associate Director, Product Development (2009–2013).
Joyce Y Zhao, PhD
LinkedInExperience: Director, Combination Product Medical Device · Takeda
Director, Combination Product Medical Device at Takeda since April 2023, and Associate Director, Combination Product Device Development at Takeda from 2019 to 2023. The listing also shows Associate Director, Combination Product Device Development at Dr. Reddy's Laboratories (2016–2018) and Staff Engineer, Technical Lead at BD (2010–2016).
Julie Ann Jones
LinkedInExperience: Director, Device Program Lead (Drug Device Combination Products) · Viatris
Director, Device Program Lead (Drug Device Combination Products) at Viatris since August 2022, a role the profile describes as leading program management teams in the development of respiratory and injectable products and building plans in line with regulatory strategies. Also Senior Manager - Lead for Combination Product Development Projects at Teva Pharmaceuticals (2018–2022).
Michael Noderer
LinkedInExperience: Head of Pharma Product Portfolio Combination Products · Bayer
Head of Pharma Product Portfolio Combination Products at Bayer since July 2020, alongside the title Senior Director Drug Delivery Systems at Bayer since May 2023. The listing also shows Associate Principal Engineer at AstraZeneca (2014–2020) and Design Authority at Sanofi (2009–2014). The profile summary, written during the AstraZeneca role, describes 15 years of work in device and combination product development.
Paul Lindstrom MSME, MBA
LinkedInExperience: Senior Director, R&D, Device and Combination Product Development · AstraZeneca
Senior Director, R&D, Device and Combination Product Development at AstraZeneca since August 2021, with the listing also showing Director, R&D, Device and Combination Product Development there since 2019. Other listed roles include CMC Scientific Director, Combination Product Development (2015–2016) and Director Tec Ops, Combination Products (2013–2015) at AbbVie.
Paul Roussel
LinkedInExperience: Senior Director-Combination Products · Kiniksa Pharmaceuticals
Senior Director-Combination Products at Kiniksa Pharmaceuticals since April 2019. The profile describes a combination products focus on device development, providing engineering leadership in concept development, prototyping, mechanical and biocompatibility evaluation, process and equipment development and production scale up. The listing also shows Associate Director at MedImmune since 2016 and Principal Scientist there (2014–2016).
Roger Liu
LinkedInExperience: Director-Combination Product Development · AbbVie
Director-Combination Product Development at AbbVie since July 2017. The profile lists areas including combination product and project management from conception through development and commercialization, delivery device technologies, engineering and design controls, and clinical drug product and OEM device integration. Other listed roles include Director- Delivery Systems Development at MedImmune (2015–2017) and Associate Director - Delivery Devices at Biogen (2008–2013).
Shirley Aguirre Baron
LinkedInExperience: Director of Devices and Combination Products at Alexion · AstraZeneca
Director of Devices and Combination Products at Alexion, at AstraZeneca, since April 2025. The listing also shows Global Lead of Combination Products at Chugai, at Roche (2020–2023), Director, Injectables Portfolio Lead at Viatris (2023–2025) and Engineering Project Manager - Combination Products at Owen Mumford (2016–2019).
Choose the right perspective
Match the person's seat to your question, since leading a company-wide device and combination product function differs from running one device program or portfolio. Also consider the device formats and development stage they worked on, because early device selection raises different questions than late-stage development, submission and launch.
Questions to take into the conversation
- 01How do you decide whether to use an off-the-shelf delivery device or develop a custom one for a new drug?
- 02How should device development, drug product development and regulatory teams split responsibilities on a combination product?
- 03What tends to cause delays when moving a combination product from clinical supply into commercial launch?
Reaching combination product development experts
How can I contact one of these combination product development experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 9 companies, including Eli Lilly and Company, Teva Pharmaceuticals and Merck, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach combination product development experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal